Buffalo, NY 的 伯基特淋巴瘤 臨床試驗
8 項針對 伯基特淋巴瘤 的研究正在 Buffalo（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- Roswell Park Cancer Institute, Buffalo
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
招募中3 期
- Roswell Park Cancer Institute, Buffalo
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- Roswell Park Cancer Institute, Buffalo
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- Roswell Park Cancer Institute, Buffalo
Study of SGR-1505 in Mature B-Cell Neoplasms
招募中1 期
- Roswell Park Comprehensive Cancer Center, Buffalo
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
招募中1 期
- Roswell Park Comprehensive Cancer Center, Buffalo
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
招募中1/2 期
- Roswell Park Comprehensive Cancer Center, Buffalo
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
招募中2 期
- Roswell Park Cancer Institute, Buffalo
其他城市的 伯基特淋巴瘤 試驗
- Houston, TX21 項研究
- Philadelphia, PA16 項研究
- Milwaukee, WI16 項研究
- Chicago, IL15 項研究
- Cincinnati, OH13 項研究
- New York City, NY13 項研究
- Atlanta, GA12 項研究
- Aurora, CO11 項研究
- Seattle, WA11 項研究
- Durham, NC10 項研究
- Boston, MA10 項研究
- Kansas City, MO10 項研究
Buffalo 的其他研究
- 非小細胞肺癌19 項研究
- 癌症（所有類型）19 項研究
- 急性髓系白血病19 項研究
- 肺癌16 項研究
- 乳癌16 項研究
- 卵巢癌13 項研究
- 轉移性癌症11 項研究
- 前列腺癌11 項研究
- 黑色素瘤10 項研究
- 多發性骨髓瘤10 項研究
- 肥胖症9 項研究
- 骨髓增生異常症候群8 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。